BE883086A - Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs alpha - et beta-adrenergiques, et leur procede de preparation - Google Patents

Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs alpha - et beta-adrenergiques, et leur procede de preparation

Info

Publication number
BE883086A
BE883086A BE0/200446A BE200446A BE883086A BE 883086 A BE883086 A BE 883086A BE 0/200446 A BE0/200446 A BE 0/200446A BE 200446 A BE200446 A BE 200446A BE 883086 A BE883086 A BE 883086A
Authority
BE
Belgium
Prior art keywords
hydroxy
piperazinylethyl
beta
alpha
novel
Prior art date
Application number
BE0/200446A
Other languages
English (en)
Inventor
J Grisar
G Claxton
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE883086A publication Critical patent/BE883086A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/200446A 1979-05-04 1980-05-02 Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs alpha - et beta-adrenergiques, et leur procede de preparation BE883086A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,244 US4255575A (en) 1979-05-04 1979-05-04 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives

Publications (1)

Publication Number Publication Date
BE883086A true BE883086A (fr) 1980-09-01

Family

ID=21887503

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/200446A BE883086A (fr) 1979-05-04 1980-05-02 Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs alpha - et beta-adrenergiques, et leur procede de preparation

Country Status (21)

Country Link
US (1) US4255575A (fr)
JP (1) JPS55147262A (fr)
AT (1) AT376426B (fr)
AU (1) AU531738B2 (fr)
BE (1) BE883086A (fr)
CA (1) CA1138457A (fr)
CH (1) CH645368A5 (fr)
DE (1) DE3014813A1 (fr)
DK (1) DK159435C (fr)
ES (1) ES8104995A1 (fr)
FR (1) FR2455590A1 (fr)
GB (1) GB2053897B (fr)
IE (1) IE49549B1 (fr)
IL (1) IL59596A (fr)
IT (1) IT1143190B (fr)
NL (1) NL8002071A (fr)
NO (1) NO152698C (fr)
NZ (1) NZ193107A (fr)
PH (1) PH17089A (fr)
SE (1) SE447109B (fr)
ZA (1) ZA801453B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3505425A1 (de) * 1985-02-16 1986-08-21 Bayer Ag, 5090 Leverkusen 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US4956302A (en) * 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3812755A1 (de) * 1988-04-16 1989-10-26 Merck Patent Gmbh Salicylsaeurederivate
KR100484386B1 (ko) * 2000-10-04 2005-04-22 경동제약 주식회사 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(s)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
CA1113937A (fr) * 1977-04-05 1981-12-08 Frederic P. Hauck Piperidinylpropanols substitues

Also Published As

Publication number Publication date
CH645368A5 (de) 1984-09-28
NO801297L (no) 1980-11-05
GB2053897A (en) 1981-02-11
NO152698B (no) 1985-07-29
FR2455590A1 (fr) 1980-11-28
GB2053897B (en) 1982-10-20
US4255575A (en) 1981-03-10
JPS55147262A (en) 1980-11-17
ZA801453B (en) 1980-12-31
AU5707680A (en) 1980-11-06
NL8002071A (nl) 1980-11-06
SE8003244L (sv) 1980-11-05
IE49549B1 (en) 1985-10-30
PH17089A (en) 1984-05-29
SE447109B (sv) 1986-10-27
IL59596A0 (en) 1980-06-30
ES490667A0 (es) 1981-05-16
DK159435B (da) 1990-10-15
DK159435C (da) 1991-03-25
ATA232580A (de) 1984-04-15
IT1143190B (it) 1986-10-22
AT376426B (de) 1984-11-26
DE3014813A1 (de) 1980-11-13
NZ193107A (en) 1982-12-21
FR2455590B1 (fr) 1983-10-14
DK193680A (da) 1980-11-05
ES8104995A1 (es) 1981-05-16
IE800481L (en) 1980-11-04
JPS6321666B2 (fr) 1988-05-09
CA1138457A (fr) 1982-12-28
AU531738B2 (en) 1983-09-01
IL59596A (en) 1984-01-31
IT8048267A0 (it) 1980-03-26
NO152698C (no) 1985-11-20

Similar Documents

Publication Publication Date Title
BE887574R (fr) Derives de l'acide quinoleine-carboxylique et procede pour leur preparation
RO80265A (fr) Procede pour la preparation de derives de l'acide beta-carboline-3-carboxyliqye
PT77122B (fr) Procede de preparation de derives de l'acide methylenediphosphonique
MA18731A1 (fr) B-lactames derives de l'acide penicillamique et leur preparation
BE857541A (fr) Derives d'acide prostanoique et leur procede de preparation
RO86439A (fr) Procede pour la preparation des derives d'acide ascorbique
FR2483409B1 (fr) Derives de l'acide 3-amino-2-hydroxy butanoylaminoacetique et leur procede de preparation
FR2484418B1 (fr) Nouveaux derives d'acide isocyanurique, utiles notamment comme agents cytostatiques, et leur procede de preparation
BE883086A (fr) Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs alpha - et beta-adrenergiques, et leur procede de preparation
BE890223A (fr) Procede de preparation de derives de l'acide quinoleine-carboxylique
PT67088A (fr) Procede de preparation de derives de l'acide(phenyl-3-amino-2-propionyloxy)-2-acetique
BE887752A (fr) Derives de l'acide 7-oxo-1-azabicyclo (3,2,0) hept-2-ene-2-carboxylique, leur procede de preparation et leur application notamment comme antibiotiques
RO80004A (fr) Procede pour la preparation des derives de l'ester de l'acide cyclopropancarboxylique
BE856464A (fr) Nouveaux derives 16-acythio de l'acide fusidique, utiles notamment comme antimicrobiens et leur procede de preparation
ES490069A0 (es) Procedimiento para la preparacion de derivados de amidas de acidos 1,2,3-tiadiazol-5-carboxilicos
FR2559766B1 (fr) Procede de preparation de derives de l'acide carbamique
FR2351083A1 (fr) Procede de preparation d'acide 2-(amylbenzoyl)-benzoique
BE859239A (fr) Nouveaux esters de o-pyrazolyle d'acide n,n-dimethyl-carbamique, leur procede de preparation et leur application comme insecticides
BE886438A (fr) Procede de preparation du glucoside de l'acide mycophenolique, et glucoside ainsi obtenu
FR2274282A1 (fr) Nouveaux derives d'acide 2,4,6-triiodoisophtalamique, leur procede de preparation et leur application comme agents de contraste radiographique
BE863388A (fr) Nouveaux anilides d'acide chloromethanesulfonique, leur procede de preparation et leur application comme herbicides
BE856326A (fr) Nouveaux derives d'acide prostanoique et leur procede de preparation
BE874450A (fr) Derives d'acide 7-(2,3-dihydrobenzo-5-furannyl) acetamidocephalosporanique utiles notamment comme antibiotiques et leur procede de preparation
BE886392A (fr) Procede de preparation de l'acide trimellitique
PT68159A (fr) Procede de preparation de nouveaux derives de l'acide piperazinecarbodithioique

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RICHARDSON-MERRELL INC.

Effective date: 20000502